Systematic review demonstrates narrow band imaging improves diagnosis and surveillance in head and neck cancer, suggesting enhanced precision and outcomes.
Introduction: This study aimed to systematically review the application of narrow band imaging (NBI) in the diagnosis, treatment, and follow-up of head and neck cancer. Methods: Through literature review and generalization of our clinical experiences, this review thoroughly described the features, mechanisms, advantages, drawbacks, and prospects of NBI in the treatment of head and neck cancer. Results: NBI is an emerging endoscopic technology that emits an ambient light at wavelengths of 415 nm (blue) and 540 nm (green) to clearly visualize the details on the mucosal surface. It presents potent efficiencies in the preoperative, intraoperative, and postoperative surveillance and diagnosis of head and neck cancer. Conclusion: NBI is a front-edge imaging technology that allows early screening, precise treatment, and postoperative monitoring of head and neck cancer.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: